07/07/2023
Because many I know and love suffer and have suffered from this debilitating disease, our AMNY Friday Feature (back from a short summer vacation hiatus) shares the announcement that the FDA U.S. Food and Drug Administration has approved Biogen's Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. While this is not an endorsement of the drug, it is a note of appreciation that medical research is advancing in this area: https://lnkd.in/g_C_2vpw
The FDA approved Leqembi (lecanemab-irmb), the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiol